NASDAQ:GBSN (GBSN) (GBSN) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free GBSN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$0.10▼$0.1250-Day Range N/A52-Week Range$0.03▼$18.00Volume104,097 shsAverage Volume99,205 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (GBSN) alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. About (GBSN) Stock (NASDAQ:GBSN)Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.Read More Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. GBSN Stock News HeadlinesApril 17, 2024 | thetimes.co.ukPolice close in on ‘gang behind biggest gold heist in Canadian history’January 12, 2024 | msn.comFEATURED: University of Kigali appoints Professor Ogechi Adeola as Deputy Vice-Chancellor – AcademicApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 12, 2023 | msn.comBlake Lively fans wowed by Seventies-inspired gold jumpsuit at New York Fashion WeekSeptember 12, 2023 | msn.comBrian Wilson so strung out on drugs he forgot he met John Lennon THREE times at same party: ‘He was toasted by demons and lost in a fog!’September 4, 2023 | msn.comAngels drop 3rd in a row to A’s as pitching, defense falterSeptember 3, 2023 | msn.comArizona volleyball wins uneven 5-setter against GCU to improve to .500 on the seasonSeptember 3, 2023 | msn.comLithuania gives Steve Kerr a bit of his own medicine as Team USA suffers their first defeat in the 2023 FIBA World CupApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 3, 2023 | msn.comDame Judi Dench 'emotional' on Countryfile as she spots golden eagle in ScotlandMay 11, 2023 | msn.comCreamy Roasted Red Pepper DipApril 9, 2023 | thestreet.comHere’s Why Great Basin Scientific (GBSN) Stock is Surging TodayFebruary 19, 2023 | msn.comWestmoreland Police searching for missing 8-year-old boyDecember 28, 2022 | msn.comStar player absolutely blasts field conditionsDecember 28, 2022 | msn.comNick Sirianni: Motivation this week is to get top seed, but helping draft position would be sweetNovember 29, 2022 | msn.comSupporting teachersOctober 6, 2022 | msn.comMP Materials Corp. (MP) Stock Moves -0.42%: What You Should KnowSeptember 27, 2022 | msn.comWatch | Nasa crashes Dart spacecraft on asteroid, Armageddon styleSeptember 26, 2022 | msn.comWatch LIVE | Nasa crashes Dart spacecraft on asteroid, Armageddon styleSeptember 12, 2022 | msn.comLudhiana | September 30 last date to get rebate, 81K property owners to pay taxSeptember 12, 2022 | msn.com37 arrested in illegal gambling operationsAugust 16, 2022 | investing.comGreat Basin Scientific Inc (GBSNQ)August 3, 2022 | msn.comSpecial photo exhibition featuring dogs that are up for adoption on display at Bucharest's Suțu PalaceJanuary 19, 2022 | thestreet.comGreat Basin Scientific (GBSN) Stock Surges Today After Patent IssuanceJanuary 15, 2022 | thestreet.comOne Reason Great Basin Scientific (GBSN) Stock is Rising TodayJanuary 14, 2022 | thestreet.comGreat Basin Scientific (GBSN) Stock Jumps After Receiving European PatentNovember 15, 2021 | marketscreener.comGB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.comSee More Headlines Receive GBSN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (GBSN) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/22/2017Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:GBSN CUSIPN/A CIK1512138 Webgbscience.com Phone+1-801-9901055FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDavid Spafford (Age 55)Executive Chairman of the Board Robert Jenison (Age 50)Senior Vice President - Research, Chief Technology Officer Ryan Ashton (Age 56)President, Chief Executive Officer, Director Kirk K. Calhoun (Age 73)Independent Director Sam Chawla (Age 41)Independent Director Ronald K. Labrum (Age 60)Independent Director More Executives GBSN Stock Analysis - Frequently Asked Questions How were (GBSN)'s earnings last quarter? (GBSN) (NASDAQ:GBSN) issued its quarterly earnings results on Wednesday, March, 22nd. The medical research company reported ($18.25) EPS for the quarter. The medical research company had revenue of $0.85 million for the quarter. When did (GBSN)'s stock split? Shares of (GBSN) reverse split on the morning of Friday, September 16th 2016. The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 15th 2016. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What other stocks do shareholders of (GBSN) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (GBSN) investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), (BBEPQ) (BBEPQ), (UPLMQ) (UPLMQ), VelocityShares Daily 2x VIX Short-Term ETN (TVIX), U.S. Energy (USEG), Synergy Pharmaceuticals (SGYP), BioCryst Pharmaceuticals (BCRX) and Linn Energy (LINEQ). This page (NASDAQ:GBSN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (GBSN) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
